new IV immune globulin called RespiGam

You'll see a new IV immune globulin called RespiGam...formulated to PREVENT Respiratory Syncytial Virus (RSV) disease in children.

RSV is the leading cause of pneumonia in infants. Those at highest risk are premature infants...and children under age two with bronchopulmonary dysplasia (BPD).

Although RSV isn't increasing in incidence, it's being recognized and diagnosed more often.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote